Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Equity Ratio (2016 - 2025)

Standard Biotools (LAB) has disclosed Equity Ratio for 16 consecutive years, with 0.74 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio rose 3.15% to 0.74 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.74, a 3.15% increase, with the full-year FY2024 number at 0.77, up 268.1% from a year prior.
  • Equity Ratio was 0.74 for Q3 2025 at Standard Biotools, down from 0.76 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.78 in Q1 2025 to a low of 0.46 in Q4 2023.
  • A 5-year average of 0.26 and a median of 0.35 in 2021 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: crashed 421.47% in 2023, then skyrocketed 383.99% in 2024.
  • Standard Biotools' Equity Ratio stood at 0.34 in 2021, then crashed by 160.73% to 0.21 in 2022, then tumbled by 119.56% to 0.46 in 2023, then skyrocketed by 268.1% to 0.77 in 2024, then decreased by 3.86% to 0.74 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Equity Ratio are 0.74 (Q3 2025), 0.76 (Q2 2025), and 0.78 (Q1 2025).